| Product Code: ETC8416059 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Morocco Pharmacogenetic Testing Market Overview |
3.1 Morocco Country Macro Economic Indicators |
3.2 Morocco Pharmacogenetic Testing Market Revenues & Volume, 2021 & 2031F |
3.3 Morocco Pharmacogenetic Testing Market - Industry Life Cycle |
3.4 Morocco Pharmacogenetic Testing Market - Porter's Five Forces |
3.5 Morocco Pharmacogenetic Testing Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Morocco Pharmacogenetic Testing Market Revenues & Volume Share, By Gene Type, 2021 & 2031F |
3.7 Morocco Pharmacogenetic Testing Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.8 Morocco Pharmacogenetic Testing Market Revenues & Volume Share, By Sample, 2021 & 2031F |
3.9 Morocco Pharmacogenetic Testing Market Revenues & Volume Share, By Therapeutic Area, 2021 & 2031F |
3.10 Morocco Pharmacogenetic Testing Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.11 Morocco Pharmacogenetic Testing Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Morocco Pharmacogenetic Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for personalized medicine |
4.2.2 Growing awareness about the benefits of pharmacogenetic testing |
4.2.3 Rise in chronic diseases requiring personalized treatment |
4.3 Market Restraints |
4.3.1 Lack of skilled professionals in pharmacogenetics |
4.3.2 High costs associated with pharmacogenetic testing |
4.3.3 Limited insurance coverage for pharmacogenetic testing |
5 Morocco Pharmacogenetic Testing Market Trends |
6 Morocco Pharmacogenetic Testing Market, By Types |
6.1 Morocco Pharmacogenetic Testing Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Morocco Pharmacogenetic Testing Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Morocco Pharmacogenetic Testing Market Revenues & Volume, By Whole Genome Sequencing, 2021- 2031F |
6.1.4 Morocco Pharmacogenetic Testing Market Revenues & Volume, By Whole Exome Sequencing, 2021- 2031F |
6.1.5 Morocco Pharmacogenetic Testing Market Revenues & Volume, By Array-Based Tests, 2021- 2031F |
6.1.6 Morocco Pharmacogenetic Testing Market Revenues & Volume, By Single Gene Tests, 2021- 2031F |
6.2 Morocco Pharmacogenetic Testing Market, By Gene Type |
6.2.1 Overview and Analysis |
6.2.2 Morocco Pharmacogenetic Testing Market Revenues & Volume, By CYP2C19, 2021- 2031F |
6.2.3 Morocco Pharmacogenetic Testing Market Revenues & Volume, By CYP2D6, 2021- 2031F |
6.2.4 Morocco Pharmacogenetic Testing Market Revenues & Volume, By CYP2C9 and VKORC1, 2021- 2031F |
6.2.5 Morocco Pharmacogenetic Testing Market Revenues & Volume, By CYP1A2, 2021- 2031F |
6.2.6 Morocco Pharmacogenetic Testing Market Revenues & Volume, By HLA-B*1502, 2021- 2031F |
6.2.7 Morocco Pharmacogenetic Testing Market Revenues & Volume, By HLA-B*5701, 2021- 2031F |
6.3 Morocco Pharmacogenetic Testing Market, By Drug Type |
6.3.1 Overview and Analysis |
6.3.2 Morocco Pharmacogenetic Testing Market Revenues & Volume, By Prescription Drugs, 2021- 2031F |
6.3.3 Morocco Pharmacogenetic Testing Market Revenues & Volume, By Nutraceuticals, 2021- 2031F |
6.3.4 Morocco Pharmacogenetic Testing Market Revenues & Volume, By Recreational Drugs, 2021- 2031F |
6.3.5 Morocco Pharmacogenetic Testing Market Revenues & Volume, By Herbal Supplements, 2021- 2031F |
6.3.6 Morocco Pharmacogenetic Testing Market Revenues & Volume, By Vitamins, 2021- 2031F |
6.3.7 Morocco Pharmacogenetic Testing Market Revenues & Volume, By Over-the-Counter Medications, 2021- 2031F |
6.4 Morocco Pharmacogenetic Testing Market, By Sample |
6.4.1 Overview and Analysis |
6.4.2 Morocco Pharmacogenetic Testing Market Revenues & Volume, By Blood, 2021- 2031F |
6.4.3 Morocco Pharmacogenetic Testing Market Revenues & Volume, By Saliva, 2021- 2031F |
6.5 Morocco Pharmacogenetic Testing Market, By Therapeutic Area |
6.5.1 Overview and Analysis |
6.5.2 Morocco Pharmacogenetic Testing Market Revenues & Volume, By Cardiology, 2021- 2031F |
6.5.3 Morocco Pharmacogenetic Testing Market Revenues & Volume, By Gastroenterology, 2021- 2031F |
6.5.4 Morocco Pharmacogenetic Testing Market Revenues & Volume, By Anesthesiology, 2021- 2031F |
6.5.5 Morocco Pharmacogenetic Testing Market Revenues & Volume, By Genomics, 2021- 2031F |
6.5.6 Morocco Pharmacogenetic Testing Market Revenues & Volume, By Endocrinology, 2021- 2031F |
6.5.7 Morocco Pharmacogenetic Testing Market Revenues & Volume, By Immunology & Hypersensitivity, 2021- 2031F |
6.5.8 Morocco Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.5.9 Morocco Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Morocco Pharmacogenetic Testing Market, By Application |
6.6.1 Overview and Analysis |
6.6.2 Morocco Pharmacogenetic Testing Market Revenues & Volume, By Clinical Practice, 2021- 2031F |
6.6.3 Morocco Pharmacogenetic Testing Market Revenues & Volume, By Drug Development, 2021- 2031F |
6.6.4 Morocco Pharmacogenetic Testing Market Revenues & Volume, By Drug Regulation, 2021- 2031F |
6.7 Morocco Pharmacogenetic Testing Market, By End User |
6.7.1 Overview and Analysis |
6.7.2 Morocco Pharmacogenetic Testing Market Revenues & Volume, By Healthcare Providers, 2021- 2031F |
6.7.3 Morocco Pharmacogenetic Testing Market Revenues & Volume, By Pharmaceutical & Biotechnology Companies, 2021- 2031F |
6.7.4 Morocco Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.7.5 Morocco Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
7 Morocco Pharmacogenetic Testing Market Import-Export Trade Statistics |
7.1 Morocco Pharmacogenetic Testing Market Export to Major Countries |
7.2 Morocco Pharmacogenetic Testing Market Imports from Major Countries |
8 Morocco Pharmacogenetic Testing Market Key Performance Indicators |
8.1 Adoption rate of pharmacogenetic testing by healthcare providers |
8.2 Number of research studies and publications on pharmacogenetics in Morocco |
8.3 Rate of integration of pharmacogenetic testing in clinical practice in Morocco |
9 Morocco Pharmacogenetic Testing Market - Opportunity Assessment |
9.1 Morocco Pharmacogenetic Testing Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Morocco Pharmacogenetic Testing Market Opportunity Assessment, By Gene Type, 2021 & 2031F |
9.3 Morocco Pharmacogenetic Testing Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.4 Morocco Pharmacogenetic Testing Market Opportunity Assessment, By Sample, 2021 & 2031F |
9.5 Morocco Pharmacogenetic Testing Market Opportunity Assessment, By Therapeutic Area, 2021 & 2031F |
9.6 Morocco Pharmacogenetic Testing Market Opportunity Assessment, By Application, 2021 & 2031F |
9.7 Morocco Pharmacogenetic Testing Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Morocco Pharmacogenetic Testing Market - Competitive Landscape |
10.1 Morocco Pharmacogenetic Testing Market Revenue Share, By Companies, 2024 |
10.2 Morocco Pharmacogenetic Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here